Active pharmaceutical ingredient concurrent validation allowed in draft GMP guidance.
This article was originally published in The Tan Sheet
Executive Summary
API CONCURRENT VALIDATION PERMITTED IN FDA DRAFT GMP GUIDANCE recently released by the agency. The most recent draft of FDA's guidance, "Manufacturing, Processing or Holding Active Pharmaceutical Ingredients," permits concurrent validation for APIs involved in clinical trials. The document is available on FDA's Web site (www.fda.gov). Written comments will be accepted by the agency through May 18.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning